TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/28/24 17:00 | 5/24/24 | OLMA | Olema Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Zojwalla Naseem | CA | O | CHIEF ME | M.d | 46 | 4.87 | 0 | 9 | 12 | 90 | D | ||||||||||||||
3/20/24 17:30 | 3/18/24 | OLMA | Olema Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Zojwalla Naseem | CA | O | CHIEF ME | M.d | 67 | 4.87 | 0 | 14 | 21 | 80 | D | ||||||||||||||
1/29/24 07:30 | 1/25/24 | OLMA | Olema Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Zojwalla Naseem | CA | O | CHIEF ME | M.d | 140 | 7.02 | 0 | 20 | 43 | 67 | D | ||||||||||||||
12/12/23 17:55 | 12/11/23 | OLMA | Olema Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Zojwalla Naseem | CA | O | CHIEF ME | M.d | 20 | 7.02 | 0 | 3 | 7 | 47 | D | ||||||||||||||
12/7/23 20:30 | 12/6/23 | OLMA | Olema Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Zojwalla Naseem | CA | O | CHIEF ME | M.d | 92 | 7.02 | 0 | 13 | 43 | 44 | D | ||||||||||||||
11/22/23 19:00 | 11/21/23 | OLMA | Olema Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Zojwalla Naseem | CA | O | CHIEF ME | S.m | -209 | 14.38 | 0 | -15 | -32 | 31 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |